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Tbjectives: Pulmonary metastasectomy is accepted as an effective treatment for
roperly selected patients with metastatic lung tumors. In such patients, the presence
f mediastinal and/or hilar lymph node metastasis is a significant negative prog-
ostic factor. The purpose of this study was to evaluate the usefulness of endo-
ronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for
he detection of mediastinal and hilar lymph node metastasis in patients with
otentially resectable metastatic lung tumors.
ethods: Patients with metastatic lung tumors with radiologically defined medias-
inal and/or hilar lymph nodes on chest computed tomographic scans referred to our
epartment for pulmonary resection were retrospectively analyzed. Successful
ymph node aspiration was evidenced by the presence of malignant cells or normal
ymphocytes. Cytologic and histologic analysis was used to confirm metastasis in
urgically resected specimens unless metastasis was proven by EBUS-TBNA.
esults: A total of 106 patients were referred for metastasectomy during the study
eriod. EBUS-TBNA was performed in 60 lymph nodes (37 mediastinal and 23
ilar nodes) from 43 patients. Cytologic and/or histologic samples were diagnostic
n 41 (95.3%) patients. EBUS-TBNA detected lymph node metastasis in 23 patients.
he sensitivity, specificity, and diagnostic accuracy rate of EBUS-TBNA for diag-
osis of mediastinal and hilar lymph node metastasis were 92.0%, 100%, and
5.3%, respectively.
onclusions: EBUS-TBNA is a highly sensitive modality for the evaluation of
ediastinal and hilar lymph node metastasis in patients with metastatic lung tumors.
BUS-TBNA allows preoperative histologic as well as cytologic evaluation of
ediastinal and hilar lymph nodes.
ince Barney and Churchill1 reported the long-term survival of a patient w
metastatic lung tumor in the kidney in 1939, pulmonary metastasectomy has
been widely adopted and surgical resection of pulmonary metastasis is
onsidered a standard therapeutic procedure in properly selected patients. Removal
f metastatic lung tumors from extrapulmonary neoplasms has been shown to
mprove patient survival.2-6 However, clinical evidence indicates that patients w
ediastinal and/or hilar lymph node metastasis have a poor prognosis.7-9 Therefore,
ccurate mediastinal and hilar lymph node staging is critical for selecting patients
uitable for metastasectomy. Although mediastinoscopy remains the gold standard
or evaluation of the mediastinum, this procedure requires general anesthesia and is
ssociated with certain complications, such as bleeding, recurrent nerve damage,
he Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 6 1485
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G
TSnd thoracic duct injury. Herein, we describe the use of
ndobronchial ultrasound-guided transbronchial needle as-
iration (EBUS-TBNA), a minimally invasive procedure
erformed with the patient under local anesthesia, which
nables mediastinal and hilar lymph node assessment with
igh sensitivity in patients with metastatic lung tumors from
xtrapulmonary neoplasms.10-15
atients and Methods
atients
e performed a retrospective chart review of patients with sus-
ected or pathologically established metastatic lung tumors re-
erred to the Department of Thoracic Surgery, Chiba University
ospital, from June 2002 to December 2006. Chest computed
omography (CT) was performed with single-injection contrast and
ultidetector-row CT (Light Speed; GE Medical System, Milwau-
ee, Wis). EBUS-TBNA was performed in patients with radiolog-
cally defined mediastinal and/or hilar lymph nodes with a short
xis of 5 mm or more on enhanced chest CT. A total of 106
atients with proven or suspected metastatic lung tumors were
eferred for metastasectomy during the study period. Forty-three
atients fulfilled these criteria and were included and 63 patients
ere excluded owing to the cutoff value of the lymph node size in
his study. In all patients, the diagnosis of metastatic lung tumor
rom extrapulmonary lesion was established by preoperative bi-
psy or by final pathologic diagnosis of resected specimens. Pa-
ients with primary lung cancer were excluded from the study.
ymph node stations and numbers were determined according to
he Japan Lung Cancer Society Classification.16 Written informed
onsent was obtained from all patients included in this study.
BUS-TBNA
BUS-TBNA was performed on an outpatient basis in patients
nder conscious sedation. Local anesthesia was achieved with 5
L nebulized 1% lidocaine solution in the pharynx. A 2-mL bolus
ose of 2% lidocaine was also used during the procedure. The
ronchoscope was inserted orally during midazolam-induced con-
cious sedation. Patients underwent electrocardiography, pulse
ximetry, and blood pressure monitoring without the presence of
n anesthesiologist. Convex probe EBUS (BF-UC260F-OL8;
lympus, Tokyo, Japan) was used to examine mediastinal and
ilar lymph nodes. The convex probe EBUS is integrated with a
onvex transducer (7.5 MHz) that scans parallel to the insertion
irection of the bronchoscope. Images can be obtained by directly
ontacting the probe or by attaching a balloon on the tip and
nflating with saline. The ultrasound image is processed in a
edicated ultrasound scanner (EU-C2000; Olympus) and is visu-
lized along with the conventional bronchoscopy image on the
Abbreviations and Acronyms
CT  computed tomography
EBUS-TBNA endobronchial ultrasound-guided
transbronchial needle aspirationame monitor. A dedicated 22-gauge needle was used to perform T
486 The Journal of Thoracic and Cardiovascular Surgery ● Decransbronchial needle aspiration (NA-201SX-4022; Olympus).
he inner diameter of this needle is nearly equal to that of con-
entional 21-gauge needles, which allows sampling of histologic
ores. The needle is also equipped with an internal sheath that is
ithdrawn after passing the bronchial wall, avoiding contamina-
ion during EBUS-TBNA. The needle can be visualized through
he optic device and on the ultrasound image.
ymph Node Sampling
he dedicated 22-gauge needle was used for lymph node sampling.
fter the initial puncture, the internal sheath was used to clean out
he internal lumen, which becomes clogged with bronchial mem-
rane. The internal sheath is then removed and negative pressure
s applied with a syringe. After the needle is moved back and forth
nside the lymph node, the needle is retrieved and the internal
heath is used once again to push out the histologic core.11 With
his method, histologic cores as well as cytologic specimens can be
btained. The aspirated material was smeared onto glass slides,
nd smears were air-dried and immediately stained with Diff-Quik
Sysmex Corporation, Kobe, Japan) for immediate interpretation
y an on-site cytopathologist to confirm adequate cell material.
urthermore, Papanicolaou staining and light microscopy were
erformed by an independent cytopathologist who was blinded to
he details of patient information. Histologic cores were fixed with
ormalin and stained with hematoxylin and eosin. Immunohisto-
hemistry was also performed in some patients.
EBUS-TBNA diagnosis was confirmed by open thoracotomy,
horacoscopy, or clinical follow-up. In patients with malignant
ymph nodes, the determination was based on malignant cytologic
nd/or histologic results at EBUS-TBNA or surgical–pathologic
onfirmation. In patients with benign lymph nodes, this determi-
ation was based on surgical pathologic confirmation of EBUS-
BNA–targeted nodes by lymph node dissection of the lymph
ode station of interest or results of clinical follow-up for at least
months demonstrating a lack of clinical or radiologic disease
rogression.
ata Analysis
he sensitivity, specificity, positive predictive value, negative pre-
ictive value, and diagnostic accuracy rate were calculated by
tandard definitions. This study was approved by the ethical com-
ittee at our institute and a written consent form was obtained
rom all the patients who participated in the study.
esults
atient Characteristics
haracteristics of the 43 patients who participated in this
tudy are listed in Table 1. Sixty lymph nodes (37 m
inal and 23 hilar lymph nodes) were evaluated. There were
7 men and 16 women, and the average age was 63.3 years.
he primary malignancy sites are listed in Table 1.
BUS-TBNA Results
he subcarinal lymph node (#7) and interlobar lymph node
#11) were the most frequently punctured lymph node sta-
ions (Table 2). Lymph node stations assessed by EB
BNA are shown in Table 2. The short axes of the lymph
ember 2007
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G
TSodes based on chest CT and EBUS ranged from 5 to 35
m and 3.9 to 28.8 mm, respectively (Table 2). The
ionship between lymph node size on CT scan and likeli-
ood of metastasis is described in Table 3. Four (36.4%
1 lymph nodes with a short axis of 5 mm lymph node
0 mm on CT were positive for metastasis. In addition, 9
ABLE 1. Patient characteristics
ge (y)
Mean 63.3
Range 31–83
ender (n  43)
Male 27
Female 16
rimary tumor type Metastatic rate
Colorectal cancer 16 9/16 (56.3%)
Head and neck cancer 8 2/8 (25%)*
Breast cancer 6 4/6 (66.7%)
Renal cell carcinoma 5 4/5 (80%)
Esophageal cancer 2 0/2 (0%)
Ovarian cancer 1 1/1 (100%)
Hepatocellular carcinoma 1 1/1 (100%)
Prostate cancer 1 1/1 (100%)
Germ cell tumor 1 1/1 (100%)
Malignant melanoma 1 1/1 (100%)
Eccrine carcinoma 1 0/1 (0%)
o. of metastatic lesions
Solitary 32
Multiple (2-4 lesions) 11
Mean 1.42
isease-free interval
Range (mo) 0.26–211.72
Mean (mo) 44.27
Two patients in whom endobronchial ultrasound-guided transbronchial
eedle aspiration was not diagnostic.
ABLE 2. Lymph node stations assessed by EBUS-TBNA
CT, mean size
in mm (range)
EBUS, mean size
in mm (range)
tation
#1 (n  1) 20 20.0
#3 (n  15) 12 (5–28) 10.5 (3.9–21.4)
#3p (n  2) 10 (10–10) 11.2 (8.2–14.2)
#4 (n  2) 7 (5–9) 7.3 (6.3–8.3)
#7 (n  17) 11 (5–21) 13.9 (7.9–21.7)
#10 (n  5) 13 (10–16) 16.3 (10.9–20.2)
#11 (n  17) 16 (8–35) 14.9 (7.6–28.8)
#12 (n  1) 14 14.4
egional
Mediastinum (n  37)
Hilar or lobar (n  23)
ean (range), n  60 13.1 (5–35) 13.6 (3.9–28.8)
BUS-TBNA, Endobronchial ultrasound-guided transbronchial needle as-
iration; CT, computed tomography. 9
The Journal of Thoracic-
f
33.3%) of 27 lymph nodes were positive for metastasis
ven for nodes less than 15 mm on CT (Table 3). Path
iagnosis was achieved in 41 (95.3%) of 43 patients, and
ymph node metastases were diagnosed in 23 patients. In 2
atients, specimens obtained by EBUS-TBNA were inade-
uate for pathologic evaluation (no lymphocytes in the
ample). These 2 patients had metastasis in the final resected
pecimen, and therefore their results were considered false
egative. The sensitivity, specificity, diagnostic accuracy
ate, positive predictive value, and negative predictive value
f EBUS-TBNA for diagnosis of mediastinal and hilar
ymph node metastasis were 92.0%, 100%, 95.3%, 100%,
nd 90%, respectively (Table 4). Histologic cores w
btained in 28 (65.1%) of the 43 patients. In all 23 patients,
ymph node metastasis was diagnosed by pathologic exam-
nation (in 7 patients by cytologic examination alone, in 14
atients by both cytologic and histologic examination, and
n 2 patients by histologic examination alone). Immunohis-
ochemistry was additionally performed in 7 patients (2 with
olorectal cancer, 1 with renal cell carcinoma, 1 with pros-
ate cancer, 1 with melanoma, 1 with thyroid cancer, and 1
ith ovarian cancer) (Figures 1 and 2).
Twenty of 23 patients with lymph node metastases re-
eived chemotherapy or immunotherapy. No patients had
ny complications related to EBUS-TBNA.
iscussion
his is the first study to evaluate the efficacy of EBUS-
BNA in the preoperative detection of mediastinal and/or
ABLE 3. Association between lymph node size on CT
can and likelihood of metastasis
hort axis on CT n
Negative for
metastasis
Positive for
metastasis
mm  LN  10 mm 11 7 4
0 mm  LN  15 mm 16 11 5
5 mm  LN  20 mm 6 2 4
0 mm  LN 10 0 10
ean (n  43) 9.53 mm 16.75 mm
T, Computed tomography; LN, lymph node.
ABLE 4. Comparison of EBUS-TBNA results of lymph
odes with final diagnosis
inal diagnosis
EBUS-TBNA results
Malignant Benign Total
alignant 23 2* 25
enign 0 18 18
otal 23 20 43
BUS-TBNA, Endobronchial ultrasound-guided transbronchial needle as-
iration. The sensitivity, specificity, and diagnostic accuracy rate of EBUS-
BNA for diagnosis of mediastinal and hilar lymph node metastasis were
2.0%, 100%, and 95.3%, respectively. *Inadequate specimen.
and Cardiovascular Surgery ● Volume 134, Number 6 1487
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G
TSFigure 1. Chest CT showed subcarinal lymph
node enlargement (A). EBUS-TBNA was per-
formed for the enlarged subcarinal lymph node
(B). Cytologic findings showed atypical columnar
cells with Papanicolaou stain (C). Histologic
findings revealed adenocarcinoma with palisad-
ing proliferation (D). Immunohistochemical anal-
ysis revealed that tumor cells were negative for
thyroid transcription factor-1 (E) and positive
(brown stain) for CDX2 (F). LN, Lymph node.Figure 2. Chest CT showed an enhanced pretra-
cheal lymph node enlargement (A). Convex probe
EBUS showed the enlarged pretracheal lymph
node (B). Histologic findings showed tumor cells
with clear cytoplasm arranged in nests sepa-
rated by fibrous septa (C). Immunohistochemical
analysis showed CD10-positive epithelial tumor
cells (D). LN, Lymph node; SVC, superior vena
cava.488 The Journal of Thoracic and Cardiovascular Surgery ● December 2007
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G
TSilar lymph node metastasis in patients with metastatic lung
umor from extrapulmonary lesions. From our experience in
atients with lung cancer, lymph nodes measuring 5 mm or
arger can clearly be detected by EBUS and can be sampled
y EBUS-TBNA. Hence, we considered patients with me-
iastinal and/or hilar lymph nodes with a short axis of 5 mm
r more to be optimal candidates for EBUS-TBNA. From
he results of this study, 34.6% of the lymph nodes less than
0 mm in size on chest CT showed lymph node metastasis
nd 9 of 27 lymph nodes were positive for metastasis even
or nodes less than 15 mm.
Pulmonary metastasectomy is widely accepted as an
ffective treatment for properly selected patients with dif-
erent tumor types.2-6 Some investigators have reported th
atients with mediastinal or hilar lymph node metastasis
ave a poor prognosis.7-9 Although the presence of med-
stinal and/or hilar lymph node metastasis is one of the most
mportant factors for selecting patients who will benefit
rom pulmonary metastasectomy, few reports have dis-
ussed preoperative evaluation of metastases in these
odes.17 After a retrospective chart review, Ercan and -
ociates7 reported that 20 (28.6%) of 70 patients with -
static lung tumors who underwent complete lymph node
issection had mediastinal and/or hilar lymph node metas-
asis. In other reports, the rate of mediastinal and/or hilar
ymph node metastasis has ranged from 8.6% to 14.7
he metastatic rate in these nodes in our current study
56.1%) is higher than those in previous reports owing to the
esign of the current study—in this study, patients with
ymph nodes measuring less than 5 mm on CT were ex-
luded. However, our study shows that almost half of the
atients who have radiologically detectable lymph nodes
ave lymph node metastasis proven by EBUS-TBNA. The
verall prevalence of patients with lymph node metastasis in
ur series was 21.7% (23/106 patients) and is similar to the
revalence described in previous reports.7
New diagnostic modalities such as multidetector helical
T, positron emission tomography, and positron emission
omography combined with CT have been reported to be
seful for the detection of mediastinal and hilar lymph node
etastases in patients with non–small cell lung cancer.18-20
owever, the diagnostic accuracy of these imaging modal-
ties is limited because they do not allow pathologic con-
rmation. Mediastinoscopy remains the standard procedure
or diagnosis of mediastinal lymph node metastasis. Murthy
nd colleagues17 reported the importance of preoperati
etermination of resectability for metastasectomy from re-
al cell carcinoma and recommended that mediastinoscopy
s a valuable tool for optimizing patient selection. However,
ediastinoscopy is invasive, requires general anesthesia,
nd does not allow evaluation of hilar lymph nodes.
We10-12 have reported the utility of EBUS-TBNA valuation of the mediastinum in lung cancer. EBUS-TBNA
The Journal of Thoracicermits investigation of the majority of the mediastinum; in
ddition, isolation of tissue samples can be obtained for
istologic diagnosis, including immunohistochemistry.10-15
mmunohistochemistry has a great impact on the diagnosis
f metastasis from extrapulmonary lesions, because it pro-
ides additional information concerning tumor origin21
urthermore, recent advances in biomarker research enable
he use of immunohistochemistry to predict response to
ystemic therapy for certain tumors.22,23 This raises th
ossibility of “tailor-made treatment,” in which patients
ith metastatic lung tumor with lymph node involvement
ay receive different types of treatment based on the bio-
ogical nature of the tumor at the metastatic site. In addition,
BUS-TBNA is a minimally invasive procedure that can be
erformed in an outpatient setting; none of our patients has
ver had complications related to this procedure.
In conclusion, preoperative evaluation of mediastinal and
ilar lymph nodes can be performed by EBUS-TBNA in
atients with metastatic lung tumors. EBUS-TBNA allows
ytologic as well as histologic evaluation of the mediasti-
um and the hilum.
We thank Ms Fumie Saegusa and Mr Fumio Horiuchi for
upport of cytologic diagnosis.
eferences
1. Barney JD, Churchill EJ. Adenocarcinoma of the kidney with metas-
tasis to the lung cured by nephrectomy and lobectomy. J Urol. 1939;
42:269-74.
2. Kondo H, Okumura T, Ohde Y, Nakagawa K. Surgical treatment for
metastatic malignancies. Pulmonary metastasis: indications and out-
comes. Int J Clin Oncol. 2005;10:81-5.
3. Monteiro A, Arce N, Bernardo J, Eugenio L, Antunes MJ. Surgical
resection of lung metastases from epithelial tumors. Ann Thorac Surg.
2004;77:431-7.
4. Kandioler D, Kromer E, Tuchler H, End A, Muller MR, Wolner E, et
al. Long-term results after repeated surgical removal of pulmonary
metastases. Ann Thorac Surg. 1998;65:909-12.
5. Todd TR. The surgical treatment of pulmonary metastases. Chest.
1997;112:287S-90S.
6. The International Registry of Lung Metastases Writing Committee:
Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw
P, et al.Long-term results of lung metastasectomy: prognostic anal-
yses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113:
37-49.
7. Ercan S, Nichols FC, Trastek VF, Deschamps C, Allen MS, Miller DL, et
al. Prognostic significance of lymph node metastasis found during pul-
monary metastasectomy for extrapulmonary carcinoma. Ann Thorac
Surg. 2004;77:1786-91.
8. Pfannschmidt J, Muley T, Hoffmann H, Dienemann H. Prognostic
factors and survival after complete resection of pulmonary metastases
from colorectal carcinoma: experiences in 167 patients. J Thorac
Cardiovasc Surg. 2003;126:732-9.
9. Iizasa T, Suzuki M, Yoshida S, Motohashi S, Yasufuku K, Iyoda A, et
al. Prediction of prognosis and surgical indications for pulmonary
metastasectomy from colorectal cancer. Ann Thorac Surg. 2006;82:
254-60.
0. Yasufuku K, Chiyo M, Sekine Y, Chhajed PN, Shibuya K, Iizasa T, et
al. Real-time endobronchial ultrasound-guided transbronchial needle
aspiration of mediastinal and hilar lymph nodes. Chest. 2004;126:
122-8.
and Cardiovascular Surgery ● Volume 134, Number 6 1489
11
1
1
1
1
1
1
1
2
2
2
2
General Thoracic Surgery Nakajima et al
1
G
TS1. Yasufuku K, Chiyo M, Koh E, Moriya Y, Iyoda A, Sekine Y, et al.
Endobronchial ultrasound guided transbronchial needle aspiration for
staging of lung cancer. Lung Cancer. 2005;50:347-54.
2. Yasufuku K, Nakajima T, Motoori K, Sekine Y, Shibuya K, Hiroshima
K, et al. Comparison of endobronchial ultrasound, positron emission
tomography, and CT for lymph node staging of lung cancer. Chest.
2006;130:710-8.
3. Rintoul RC, Skwarski KM, Murchison JT, Wallace WA, Walker WS,
Penman ID. Endobronchial and endoscopic ultrasound-guided real-
time fine-needle aspiration for mediastinal staging. Eur Respir J.
2005;25:416-21.
4. Herth FJ, Ernst A, Eberhardt R, Vilmann P, Dienemann H, Krasnik M.
Endobronchial ultrasound-guided transbronchial needle aspiration of
lymph nodes in the radiologically normal mediastinum. Eur Respir J.
2006;28:910-4.
5. Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A. Real-time
endobronchial ultrasound guided transbronchial needle aspiration for
sampling mediastinal lymph nodes. Thorax. 2006;61:795-8.
6. The Japan Lung Cancer Society. Part I. Anatomy: The Japan Lung
Cancer Society. Classification of lung cancer. 1st English ed. Tokyo:
Kanehara and Co., Ltd; 2000. p. 1-14.
7. Murthy SC, Kim K, Rice TW, Rajeswaran J, Bukowski R, DeCamp
MM, et al. Can we predict long-term survival after pulmonary metas-
tasectomy for renal cell carcinoma? Ann Thorac Surg. 2005;79:996-
1003.
490 The Journal of Thoracic and Cardiovascular Surgery ● Dec8. Pozo-Rodriguez F, Martin de Nicolas JL, Sanchez-Nistal MA, Mal-
donado A, Garcia de Barajas S, Calero-Garcia R, et al. Accuracy of
helical computed tomography and [18F] fluorodeoxyglucose positron
emission tomography for identifying lymph node mediastinal metas-
tases in potentially resectable non-small-cell lung cancer. J Clin Oncol.
2005;23:8348-56.
9. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN,
Shigemitsu H, et al. Test performance of positron emission tomogra-
phy and computed tomography for mediastinal staging in patients with
non-small-cell lung cancer: a meta-analysis. Ann Intern Med. 2003;
139:879-92.
0. Halpern BS, Schiepers C, Weber WA, Crawford TL, Fueger BJ,
Phelps ME, et al. Presurgical staging of non–small cell lung cancer:
positron emission tomography, integrated positron emission tomogra-
phy/CT, and software image fusion. Chest. 2005;128:2289-97.
1. Nakajima T, Yasufuku K, Wong M, Iyoda A, Suzuki M, Sekine Y, et
al. Histological diagnosis of mediastinal lymph node metastasis from
renal cell carcinoma by endobronchial ultrasound guided transbron-
chial needle aspiration: a case report. Respirology. 2007;12:302-3.
2. Ross JS, Fletcher JA. The HER-2/neu oncogene in breast cancer:
prognostic factor, predictive factor, and target for therapy. Stem Cells.
1998;16:413-28.
3. Adlard JW, Richman SD, Seymour MT, Quirke P. Prediction of the
response of colorectal cancer to systemic therapy. Lancet Oncol.
2002;3:75-82.
ember 2007
